Healthtech venture capital spans digital health platforms, care delivery innovation, diagnostics, and AI-enabled clinical workflows. Our healthtech coverage tracks the funding rounds and fund strategies defining the next generation of healthcare technology.
Browse healthtech venture capital articles below.
Peak XV and Filter Capital led a $50 million (~₹472 crore) Series C for Mumbai women’s-wellness brand Nua on September 7, 2026. The company said the print mixes primary capital and secondaries. Inc42 had reported $20–25 million talks. Valuation was not disclosed. ₹500 crore annualised run rate is a company claim.
Nourish closed $100M Series C in NYC — the country's largest dietitian-led metabolic health clinic scales virtual care with real clinical outcomes.
MiRus raised $1.5B in May 2026, one of the month's largest non-AI rounds, underscoring that medical devices can still command megaround capital.
Matrix’s TJ Parker led Metriport’s $26M raise (total $28.4M) with ARTIS and Y Combinator — point-of-care patient context for One Medical, Sollis, Color and the agents behind them.
UK biotech IMU Biosciences extended its oversubscribed Series A past $53M in June 2026 to map and decode the human immune system for drug discovery.
8VC and Town Hall Ventures led Hopscotch’s $53M Series D (Aug 18, 2026). Tech-enabled primary care for 15,000+ rural patients across the Southeast — same-day access without replacing the clinician.
ARCH Venture Partners and OpenLoop backed Happy Health’s $75M financing announcement (mid-Aug 2026) for an FDA-cleared Happy Ring and physician-guided sleep platform — home diagnosis before hospital waitlists.
Garner Health raised $100M Series E led by Index Ventures in May 2026 at a $2.74B valuation, scaling its data platform for finding high-quality healthcare providers.
Mumbai’s Fundly.ai raised ~$4M equity led by Accel and Multiply Ventures plus ~$0.9M venture debt (~$4.9M) — doubling down after a 2023 $3M seed as it stacks B2B commerce, payments, and credit for pharma distribution.
Bain Capital Ventures led Forus’s $150M Series C at $3B — tripling a ~$1B May mark — as the former Tandem builds AI agents that move specialty prescriptions through insurance, assistance, and pharmacy.
Bessemer led Flagler Health’s $50M Series B (total ~$63M) for an AI-native OS that runs musculoskeletal clinics inside existing EMRs — triage, care, billing, and patient comms.
Faro AI raised $37.3M Series B co-led by Merck Global Health Innovation Fund and S32, with General Catalyst returning. Platform used by 6 of the world’s 10 largest pharma companies. Structured clinical-intent data — not chat-on-PDFs.
